GLIBA vs GLIBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GLIBA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.14 and trades at a discount to book value (P/B 0.85), these are offset by negative net profit margins (-29.54%) and stagnant revenue growth. A significant earnings miss of 66% in the most recent reported quarter further underscores the disconnect between current performance and the optimistic single-analyst target price of $68.00.
GLIBK exhibits significant financial fragility, highlighted by a weak Piotroski F-Score of 2/9 and a technical trend score of 0/100. While the company maintains a strong liquidity position with a current ratio of 3.14 and trades below book value (P/B 0.86), these are offset by a deeply negative profit margin of -29.54% and stagnant revenue growth (-0.40%). The lack of earnings growth and absence of analyst coverage suggest a value trap scenario where low valuation is justified by poor fundamental health.
Compare Another Pair
Related Comparisons
GLIBA vs GLIBK: Head-to-Head Comparison
This page compares GCI Liberty, Inc. - Series A GC (GLIBA) and GCI Liberty, Inc. (GLIBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.